Date of birth
23.04.1987
Education
Positions
Academic degrees
Files
Research work
Performance
Professional development
Performance
2024
-
Sultanaev V, Yakimova L, Nazarova A, Pillar[5]arene/albumin biosupramolecular systems for simultaneous native protein preservation and encapsulation of a water-soluble substrate//Journal of Materials Chemistry B. - 2024. - Vol., Is.. - .
-
Rakhmatullina A.R, Zolotykh M.A, Filina Y.V, Development of a novel prostate Cancer-Stroma Sphere (CSS) model for In Vitro tumor microenvironment studies//Translational Oncology. - 2024. - Vol.44, Is.. - Art. №101930.
-
Chasov V, Zmievskaya E, Ganeeva I, Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies//Antibodies. - 2024. - Vol.13, Is.1. - Art. №10.
2023
-
Топчу Ю.А. Нокаут гистоновой метилтрансферазы NSD1 приводит к снижению пролиферации и увеличению чувствительности к цисплатину клеток плоскоклеточного рака гортани./Топчу Ю.А., Тихомирова М.В., Булатов Э.Р., Абрамова З.И., Бумбер Я.А. //Сибирский онкологический журнал.-2023.-Т.22, №2.-С76-84.
F_statya_Sibirskij_onkologicheskij_zhurnal..pdf -
Sultanaev V, Yakimova L, Nazarova A, Decasubstituted Pillar[5]arene Derivatives Containing L-Tryptophan and L-Phenylalanine Residues: Non-Covalent Binding and Release of Fluorescein from Nanoparticles//International Journal of Molecular Sciences. - 2023. - Vol.24, Is.9. - Art. №7700.
-
Mironova D, Makarov E, Bilyukova I, Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups//Pharmaceuticals. - 2023. - Vol.16, Is.5. - Art. №699.
- Khadiullina R, Mirgayazova R, Davletshin D, Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry//Life. - 2023. - Vol.13, Is.1. - Art. №31.
-
Valiullina A.K, Zmievskaya E.A, Ganeeva I.A, аЁytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line//Molecular Biology Research Communications. - 2023. - Vol.12, Is.4. - P.139-148.
-
Topchu I.A, Tikhomirova M.V, Bulatov E.R, KNOCKOUT OF THE HISTONE METHYLTRANSFERASE NSD1 LEADS TO A DECREASE IN CELL PROLIFERATION AND AN INCREASE IN SENSITIVITY TO CISPLATIN IN LARYNGEAL SQUAMOUS CELL CARCINOMA//Siberian Journal of Oncology. - 2023. - Vol.22, Is.2. - P.76-84.
F_statya_Sibirskij_onkologicheskij_zhurnal..pdf - Valiullina AK, Zmievskaya EA, Ganeeva IA, Cytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line//MOLECULAR BIOLOGY RESEARCH COMMUNICATIONS. - 2023. - Vol.12, Is.4. - P.139-148.
-
Rakhmatullina A.R, Mingaleeva R.N, Gafurbaeva D.U, Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels//Journal of Personalized Medicine. - 2023. - Vol.13, Is.11. - Art. №1621.
- Valiullina Aigul Kh., Zmievskaya Ekaterina A., Ganeeva Irina A., Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell Lines//BIOMEDICINES. - 2023. - Vol.11, Is.2. - Art. №626.
2022
-
Titov A, Kaminskiy Y, Ganeeva I, Knowns and Unknowns about CAR-T Cell Dysfunction//Cancers. - 2022. - Vol.14, Is.4. - Art. №1078.
-
Nazarova, A. Encapsulation of the quercetin with interpolyelectrolyte complex based on pillar[5]arenes / A. Nazarova, L. Yakimova, O. Mostovaya, T. Kulikova, O. Mikhailova, G. Evtugyn, I. Ganeeva, E. Bulatov, I. Stoikov // Journal of Molecular Liquids. – 2022. - V. 368. - Part B. – Reg. 120807
120807
Encapsulation_of_the_quercetin.pdf - Ganeeva I, Valiullina A, Zmievskaya E, Effect of p53 activator nutlin-3a on cytokine release in peripheral blood mononuclear cells of healthy donor and patient with multiple sclerosis//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Valiullina A, Zmievskaya E, Levchuk K, Functional assessment of cytotoxic activity of NKG2D CAR-T cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Zmievskaya E, Valiullina A, Levchuk K, Molecular design of novel NKG2D chimeric antigen receptor and its ligands//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
-
Ganeeva I. Effect of p53 activator nutlin-3a on cytokine release in peripheral blood mononuclear cells of healthy donor and patient with multiple sclerosis / I. Ganeeva, A. Valiullina; E. Zmievskaya; A. Rizvanov; E. Bulatov// European Journal of Clinical Investigation - 2022 - 52 - p. 132
Eur_J_Clin_Investigation___2022______ABSTRACT_126.pdf -
Stephenson Clarke J.R, Douglas L.R, Duriez P.J, Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C//ACS Pharmacology and Translational Science. - 2022. - Vol., Is.. - .
-
Kaminskiy Y, Kuznetsova V, Kudriaeva A, Neglected, yet significant role of FOXP1 in T-cell quiescence, differentiation and exhaustion//Frontiers in Immunology. - 2022. - Vol.13, Is.. - Art. №971045.
-
Nazarova A, Yakimova L, Mostovaya O, Encapsulation of the quercetin with interpolyelectrolyte complex based on pillar[5]arenes//Journal of Molecular Liquids. - 2022. - Vol.368, Is.. - Art. №120807.
- Ganeeva Irina, Valiullina Aygul, Zmievskaya Ekaterina, Effect of p53 activator Nutlin-3a on populations of immune cells obtained from healthy donor and patient with multiple sclerosis//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.9-9.
- Valiullina AK, Zmievskaya EA, Rakhmatullina AR, Evaluation of CAR-T Cell Cytotoxicity against a Prostate Carcinoma Model//UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI. - 2022. - Vol.164, Is.2. - P.212-230.
-
Levchuk K.A, Osipova S.A, Onopchenko A.V, Experimental Study of the In Vitro and In Vivo Functional Activity of NKG2D Chimeric Antigen Receptor NKG2D in vitro ш in vivo]//Klinicheskaya Onkogematologiya/Clinical Oncohematology. - 2022. - Vol.15, Is.4. - P.327-339.
- Ganeeva Irina, Zmievskaya Ekaterina, Valiullina Aygul, Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies//BIOENGINEERING. - 2022. - Vol.9, Is.12. - Art. №808.
- Левчук, К. А., Осипова, С. А., Онопченко, А. В., Васютина, М. Л., Булатов, Э. Р., Валиуллина, А. Х., Петухов, А. В. (2022). Экспериментальное исследование функциональной активности химерного антигенного рецептора NKG2D in vitro и in vivo. Клиническая онкогематология. Фундаментальные исследования и клиническая практика, 15(4), 327-339.
- Khusainova E, Khaliulin M, Yudina O, Cytological pattern, HPV-status and expression of p16ink4a protein in cervical cancer diagnostics//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
2021
-
Gusakov, E. Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolon derivatives as new anti-cancer agents /A. Gusakov, Iu. A. Topchu, A. M. Mazitova, I. V. Dorogan, E. R. Bulatov, I. G. Serebriiskii, Z. I. Abramova, I. O. Tupaeva, O. P. Demidov, D. N. Toan, T. D. Lam, D. N. Bang, Y.A. Boumber, Y. A. Sayapin, V. I. Minkin. // RSC Advances.- 2021.- V.11.-P.4555-4571 (Q1 SJR 0,740 IF 3.119)
RSC_Advances.pdf - Titov, A.; Zmievskaya, E.; Ganeeva, I.; Valiullina, A.; Petukhov, A.; Rakhmatullina, A.; Miftakhova, R.; Fainshtein, M.; Rizvanov, A.; Bulatov, E. Adoptive Immunotherapy beyond CAR T-Cells. Cancers 2021, 13, 743. https://doi.org/10.3390/cancers13040743
-
Gusakov, E. Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolon derivatives as new anti-cancer agents /A. Gusakov, Iu. A. Topchu, A. M. Mazitova, I. V. Dorogan, E. R. Bulatov, I. G. Serebriiskii, Z. I. Abramova, I. O. Tupaeva, O. P. Demidov, D. N. Toan, T. D. Lam, D. N. Bang, Y.A. Boumber, Y. A. Sayapin, V. I. Minkin. // RSC Advances.- 2021.- V.11.-P.4555-4571(Q1 IF3.119)
F_RSC_Advances_2021.pdf -
Titov A, Zmievskaya E, Ganeeva I, Adoptive immunotherapy beyond CAR T-cells//Cancers. - 2021. - Vol.13, Is.4. - P.1-23.
-
Zmievskaya E, Valiullina A, Ganeeva I, Application of car-t cell therapy beyond oncology: Autoimmune diseases and viral infections//Biomedicines. - 2021. - Vol.9, Is.1. - P.1-13.
- Mirgayazova Regina, Khadiullina Rania, Mingaleeva Rimma, YGenerating tp53 mutant MCF7 cell line with CRISPR/cas9: cell model for targeted therapies//CELL DEATH DISCOVERY. - 2021. - Vol.7, Is.SUPPL 1. - P.9-9.
- Khadiullina R., Mirgayazova R., Chasov V., Functional restoration of mutant p53 using targeted small molecule reactivators//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.130-130.
- Mirgayazova R., Khadiullina R., Chasov V., Application of CRISPR/Cas9 gene editing to obtain cell lines with various TP53 status//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.130-131.
-
Vitaly Chasov, Mikhail Zaripov, Regina Mirgayazova, Raniya Khadiullina, Ekaterina Zmievskaya, Irina Ganeeva, Aigul Valiullina, Albert Rizvanov and Emil Bulatov Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies / Front Immunol. 2021. doi:10.3389/fimmu.2021.707734
F_Promising_New_Tools_for_Targeting_p53_Mutant_Cancers__umoral_and_Cell_Based_Immunotherapies.pdf -
Chasov V, Zaripov M, Mirgayazova R, Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies//Frontiers in Immunology. - 2021. - Vol.12, Is.. - Art. №707734.
- Valiullina A., Zmievskaya E., Zhuravleva M., Evaluation of CAR-T cells cytotoxic efficacy against 3D cell-based model of solid tumor//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.129-130.
2020
-
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, Ekaterina Zaikova, Alexey Petukhov, Regina Miftakhova, Emil Bulatov, Albert Rizvanov / Advancing CAR T-cell therapy for solid tumors: Lessons learned from lymphoma treatment // Cancers. - 2020. - Vol.12, Is.1. - Art. № 125.
-
Mirgayazova R, Khadiullina R, Chasov V, Mingaleeva R, Miftakhova R, Rizvanov A, Bulatov E. Therapeutic editing of the TP53 gene: Is CRISPR/Cas9 an option?//Genes. - 2020. - Vol.11, Is.6. - P.1-17.
-
Chasov V. Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy / V. Chasov, R. Mirgayazova, E. Zmievskaya, R. Khadiullina,
A. Valiullina, J. S. Clarke, A. Rizvanov, M. G. J. Baud, E. Bulatov // Frontiers in oncology. - 2020. - V. 10. - A. 1460.
F_fonc_10_01460.pdf -
Chasov V, Mirgayazova R, Zmievskaya E, Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy//Frontiers in Oncology. - 2020. - Vol.10, Is.. - Art. № 1460.
-
Zagidullin A, Milyukov V, Rizvanov A, Novel approaches for the rational design of PROTAC linkers//Exploration of Targeted Anti-tumor Therapy. - 2020. - Vol.1, Is.5. - P.381-390.
- Khadiullina Raniya R., Mirgayazova Regina M., Mingaleeva Rimma N., Restoring impaired functions of mutant tumor suppressor p53 using synthetic modulators//CELL DEATH DISCOVERY. - 2020. - Vol.6, Is.1. - .
- Khadiullina Raniya R., Mirgayazova Regina M., Mingaleeva Rimma N., Small molecule modulators of mutant p53 demonstrate selective cytotoxicity toward p53-Y220C cell lines//CELL DEATH DISCOVERY. - 2020. - Vol.6, Is.1. - .
- Chasov V. Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy / V. Chasov, R. Mirgayazova, E. Zmievskaya, R. Khadiullina, A. Valiullina, J. S. Clarke, A. Rizvanov, M. G. J. Baud, E. Bulatov // Frontiers in oncology. - 2020. - V. 10. - A. 1460.
- Rakhmatulllina A., Valiullina A., Petukhov A., Anti-CD19 CAR-T cells show pronounced effect on PC3M-CD19 tumor spheres//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.83-83.
2019
- Regina Sayarova, Raniya Nazyrova, Rimma Mingaleeva, Olga Kartseva, Irina Glagoleva, Natalya Alexandrova, Azzam Hamad, Razan Subani, Vitaly Chasov, Rafil Khairullin, Regina Miftakhova, Matthias Baud, Albert Rizvanov, Emil Bulatov. Selective small molecule stabilisers/activators of p53(Y220C) mutant // CELL DEATH DISCOVERY. - 2019. - Vol.5.
-
Mirgayazova R, Khadiullina R, Mingaleeva R, Chasov V, Gomzikova M, Garanina E, Rizvanov A, Bulatov E. Novel Isatin-based activator of p53 transcriptional functions in tumor cells//Molecular Biology Research Communications. - 2019. - Vol.8, Is.3. - P.119-128.
F_1_Published_MBRC53211568403000.pdf - Khadiullina R.R. Restoring impaired functions of mutant tumor supressor p53 using synthetic modulators / R.R. Khadiullina, R.M. Mirgayazova, R.N. Mingleeva, V.V. Chasov, M. Baud, A.A. Rizvanov, E.R. Bulatov // The international conference «The regulation of proteostasis in cancer«/ - 2019. - P. 24.
- Mingaleeva R., Sagdeeva A., Sayarova R., Expression of mutant p53 affects cancer cell sensitivity to topotecan//ANNALS OF ONCOLOGY. - 2019. - Vol.30, Is.. - .
-
Mingaleeva R. Expression of mutant p53 affects cancer cell sensitivity to topotecan / R. Mingaleeva, A. Sagdeeva, R. Sayarova, E. Bulatov, R.R. Miftakhova, A.A Rizvanov // Annals of Oncology. - 2019. - V. 30. - S. 5. - P. 2003
F_mdz269.021.pdf -
Valiullina A.KH. Evaluating CAR-T cells efficiency against solid tumors models / A. KH. Valiullina, R.M. Sayarova, E.A. Zmievskaya, M.O. Gomzikova, M.N. Zhuravleva, A.V. Petikhov, E.R. Bulatov, A.A. Rizvanov // ESGCT 27th Annual congress. - 2019. - P144.
F_P144_AbstractBook.pdf - Мингалеева Р.Н. Статус р53 влияет на чувствительность клеток к топотекану/ Мингалеева Р.Н., Сагъдеева А.Р., Булатов Э.Р., Мифтахова Р.Р., Ризванов А.А.// Новые концепции механизмов воспаления, аутоиммунитета и развития опухоли: материалы VII международной науч.-практ. конф. – Казань: ИД «МеДДоК», 2019. – С.56-58
-
Mirgayazova R.M. Small molecule modulators of mutant p53 demonstrate selective cytotoxicity toward p53-Y220C cell lines / R.M. Mirgayazova, R.R. Khadiullina, R.N. Mingleeva, V.V. Chasov, M. Baud, A.A. Rizvanov, E.R. Bulatov // The international conference «The regulation of proteostasis in cancer« - 2019. - P. 53.
F_Tezisy.pdf
2018
-
Vafina G., Zainutdinova E., Bulatov E., Filimonova M.N. Endonuclease from Gram-Negative Bacteria Serratia marcescens Is as Effective as Pulmozyme in the Hydrolysis of DNA in Sputum / G. Vafina, E. Zainutdinova, E. Bulatov, M.N. Filimonova // Frontiers in Pharmacology. - 2018. - Vol. 9. - Is. 114. - PP. 1-8.
F_2018_Frontiers_Nuclease.pdf - Mingaleeva R., Sayarova R., Khadiullina R., Small molecule MB725: a highly potent modulator of p53(Y220C) mutant.//MOLECULAR BIOLOGY OF THE CELL. - 2018. - Vol.29, Is.26. - .
-
Bulatov E, Zagidullin A, Valiullina A, Sayarova R, Rizvanov A. Small molecule modulators of RING-type E3 ligases: MDM and cullin families as targets//Frontiers in Pharmacology. - 2018. - Vol.9, Is.MAY. - Art. № 450.
1_MDM_CRL_Review_Published.pdf -
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites / Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey & Nickolai A. Barlev. Cell Death & Disease, 9, Article number: 897 (2018)
2018_Titov_CAR_T.pdf -
Bulatov E, Valiullina A, Sayarova R, Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases//Immunology Letters. - 2018. - Vol.202, Is.. - P.44-51.
2018_Bulatov_ImmunoLetters.pdf -
Glagoleva I., Kudriaeva A., Belogurov A., Rizvanov A., Bulatov E. Effect of Nutlin-3a, RG-7112, Carfilzomib and MG-132 on accumulation of p53 in eukaryotic HEK293 cell line//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.100-100.
2018_Glagoleva_100.pdf -
Emil Bulatov, Regina Sayarova, Rimma Mingaleeva, Regina Miftakhova, Marina Gomzikova, Yuri Ignatyev, Alexey Petukhov, Pavel Davidovich, Albert Rizvanov & Nickolai A. Barlev. Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumor. Cell Death Discovery, Volume 4, Article number: 103 (2018)
1_Bulatov_CDDisco.pdf - Valiullina A. Evaluating efficacy of anti-CD19 CAR-T cells against CD19-positive 2D and 3D solid tumor models / A. Valiullina, R. Sayarova, M. Zhuravleva, S. Kletukhina, A. Petukhov, E. Bulatov, A. Rizvanov // Abstract book «Kazan precision medicine workshop», Kazan. - September 10-12, 2018. - P. 43.
-
Valiullina A. Anti-CD19 CAR-T cells are efficient against CD19-positive 3D bioprinted solid tumor models / A. Valiullina, R. Sayarova, A. Petukhov, M. Zhuravleva, E. Bulatov, A. Rizvanov // Human Gene Therapy. – 2018. - A122.
2018_CAR_T__umanGeneTherapy.pdf -
Mingaleeva R. Small molecule MB725: a highly potent modulator of p53(Y220C) mutant / R. Mingaleeva, R. Sayarova, R. Khadiullina, O. Kartseva, I. Glagoleva, N. Alexandrova, A. Hamad, R. Subani, V. Chasov, R. Khairullin, M. Baud, A. Rizvanov, R. Miftakhova, E. Bulatov // Mol. Biol. Cell. – 2018. – P. 2949.
2018_MolBiolCell.pdf -
Valiullina A. Screening for immunosuppressive genes responsible for resistance towards CAR-T cell therapy in cancer cells / A. Valiullina, A. Petukhov, R. Sayarova, M. Zhuravleva, S. Kletukhina, S. Malanin, E. Bulatov, A. Rizvanov // Blood. – 2018. – V.132. – S.1. – P. 4965.
2018_CAR_T_Blood.pdf -
Mingaleeva R.N. Small molecule modulators of mutant p53 and their activity in genetically modified MCF7 cells / R.N. Mingaleeva, R.M. Sayarova, R.R. Nazyrova, M. Baud, A.A. Rizvanov, R.R. Miftakhova, E.R. Bulatov // Abstract book «Kazan precision medicine workshop», Kazan. - 2018. - P. 27.
Precision_medicine_2018.pdf -
Sayarova, R.M. Selective small molecule stabilisers/activators of p53(Y220C) mutant / Regina Sayarova, Raniya Nazyrova, Rimma Mingaleeva, Olga Kartseva, Irina Glagoleva, Natalya Alexandrova, Azzam Hamad, Razan Subani, Vitaly Chasov, Rafil Khairullin, Regina Miftakhova, Matthias Baud, Albert Rizvanov, Emil Bulatov // ECDO – 2018. - P. 45
ECDO2018.pdf - Aygul Valiullina, Regina Sayarova, Alexey Petukhov, Margarita Zhuravleva, Emil Bulatov, Albert Rizvanov. Anti-CD19 CAR-T cells are efficient against CD19-positive 3D bioprinted solid tumor models // HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A122-A122.
- Valiullina Aygul, Petukhov Alexey, Sayarova Regina, Screening for Immunosuppressive Genes Responsible for Resistance Towards CAR-T Cell Therapy in Cancer Cells//BLOOD. - 2018. - Vol.132, Is.. - .
- Bulatov Emil, Sayarova Regina, Mingaleeva Rimma, Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors//CELL DEATH DISCOVERY. - 2018. - Vol.4, Is.. - Art. №103.
-
Emil Bulatov (2018). E3 Ubiquitin Ligases as Targets for Small Molecule Drug Discovery: Focusing on the Cullin Ring Family. Chapter in a book «Ubiquitin Proteasome System: A Review and Directions for Research». Nova Science Publishers. (27 pages)
2017
2016
-
Emil Bulatov, Svetlana Khaiboullina, Helton José dos Reis, András Palotás, Krishnan Venkataraman, Mookambeswaran Vijayalakshmi, Albert Rizvanov. Ubiquitin-Proteasome System: Promising Therapeutic Targets in Autoimmune and Neurodegenerative Diseases//BioNanoScience. - 2016. - Vol.6, Is.4. - P.341-344.
2016_BioNanoScience_UPS.pdf - Davidovich P., Sayarova R., Valiullina A., Novel isatin-Schiff base copper (II) complexes as potential p53-activating pro-apoptotic agents.//MOLECULAR BIOLOGY OF THE CELL. - 2016. - Vol.27, Is.. - P1116.
-
Vafina G, Bulatov E, Zaynutdinova E, Filimonova M. A One-Step Protocol for Chromatographic Purification of Non-recombinant Exogenous Bacterial Enzyme: Nuclease of Serratia marcescens//BioNanoScience. - 2016. - Vol.6, Is.4. - P.335-337.
- Bulatov E., Valiullina A., Sayarova R., Inhibitors of MDM2 ubiquitin ligase as prospective modulators of autoimmunity//FEBS JOURNAL. - 2016. - Vol.283, Is.. - P.360-360.
2015
-
Bulatov, E. R. Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2):ElonginBC:Cullin5:RING-box protein 2 (Rbx2) / Е. R. Bulatov, Е. М. Martin, S. Сhatterjee, А. Knebel, S. Shimamura, А. Konijnenberg, С. Johnson, N. Zinn, Р. Grandi, F. Sobott, А. Ciulli // The Journal of Biological Chemistry. - 2015. - Vol. 290. - № 7. - Р. 4178-4191.
-
Bulatov E, Ciulli A., Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: Structure, assembly and small-molecule modulation//Biochemical Journal. - 2015. - Vol.467, Is.3. - P.365-386.
-
Gadd M.S, Bulatov E, Ciulli A., Serendipitous SAD solution for DMSO-Soaked SOCS2-ElonginC-ElonginB crystals using covalently incorporated dimethylarsenic: Insights into substrate receptor conformational flexibility in cullin RING ligases//PLoS ONE. - 2015. - Vol.10, Is.6. - Art. № e0131218.
2011
2009
-
Timur I. Abdullin, Oksana V. Bondar, Irina I. Nikitina, Emil R. Bulatov, Michail V. Morozov, Albert Kh. Hilmutdinov, Myakzyum Kh. Salakhov, Mustafa Çulha. Effect of size and protein environment on electrochemical properties of gold nanoparticles on carbon electrodes. Bioelectrochemistry, 2009, 77 (1), 37-42.
2009_Bioelectrochemistry.pdf
Электронные образовательные ресурсы (ЭОР)
Краткий курс по белковой хроматографии (8 занятий на русском языке)
https://www.youtube.com/playlist?list=PL-IRZeLRWhLvkmoEJgKZnWwt5CeGTGyAj
Дистанционное образование
Занятий во втором семестре нет
Taught disciplines
| Discipline | Curriculum | Authors | File |
| Медицинская биохимия: Принципы измерительных технологий в биохимии. Патохимия, диагностика. Биохимия злокачественного роста | 30.05.01 Medical Biochemistry, Specialist Degree Biochemische Arzt (не предусмотрено) 2013 y. |
Фаттахова А.Н. Ионова Н.Э. Абрамова З.И. Булатов Э.Р. |
 |
| Современные методы в биохимии и биотехнологии | 06.03.01 Biology, Bachelor's Degree (Биология) 2022 y. |
Булатов Э.Р. Ахунзянов А.А. |
|
| Современные методы в биохимии и биотехнологии | 06.03.01 Biology, Bachelor's Degree (Биология) 2024 y. |
Булатов Э.Р. Ахунзянов А.А. |
|
| Современные методы в биохимии и биотехнологии | 06.03.01 Biology, Bachelor's Degree (Биология) 2023 y. |
Булатов Э.Р. Ахунзянов А.А. |
|
| Work address: | 9 Parizhskoy Kommuny Str., Kazan, Academic and Research Centre of the Institute of Fundamental Medicine and Biology |
| Office number: | 428 |
| Phone: | Телеграм: @emilbulatov |
| E-mail: | bulatovemil@gmail.com |
| Google scholar: | https://scholar.google.ru/citations?user=0Av2f7QAAAAJ&hl=en |
| НИЛ Индустриальная биофармацевтика / НИЛ Биомедицинские технологии: | https://kpfu.ru/biology-medicine/struktura-instituta/openlab/gennye-i-kletochnye-tehnologii/biomedical-technologies |
| Biomedical Technologies Laboratory: | https://kpfu.ru/eng/academic-units/natural-sciences/institute-of-fundamental-medicine-and-biology/structure/openlabs/gene-and-cell-technologies/chemical-biology-group |
| Experience: |
| Scientific and pedagogical experience: |
| General experience: |
| Experience in KFU: |